Plain-English translation of NCT07280312 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new ultrasound imaging technique called ultrasound microvessel imaging (UMI) to help doctors better evaluate ovarian and adnexal lesions—abnormal growths in and around the ovaries. The new technique is designed to show blood vessel patterns more clearly than standard ultrasound, which may help doctors determine whether a lesion is more likely to be cancer before surgery.
Ovarian cancer is often diagnosed late, when it's harder to treat. Current methods for evaluating ovarian lesions before surgery have limited ability to detect small blood vessels, which is an important sign of whether a lesion might be cancerous. This study aims to see if the new ultrasound technique can improve how doctors assess these lesions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo a transvaginal ultrasound scan that includes the new ultrasound microvessel imaging technique. This scan would be performed as part of your standard care before your scheduled surgery. The study involves 40 women total and is being conducted at Mayo Clinic.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Sponsor
Mayo Clinic
Enrollment target
~40 participants
Started
January 2026
Primary completion
December 2027
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Clinical Trials Referral Office
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.